| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
You are here > Biopharmaceutical Glossary Homepage/Search Index > Newest biopharmaceutical definitions 21st century Drug discovery & development Map Informatics map Technologies map Biology & chemistry map Finding guide to terms in these glossaries Site Map accelerator mass spectrometry: Mass spectrometry adaptive clinical trials: Drug approvals and clinical trials Bayesian clinical trials: Drug approvals and clinical trials biological chemistry: Chemistry (& biology) biomathematics Algorithms biomedical polymers: Biomaterials biomolecular screening: Assays & screening chaperome: -Omes & -omics cellular dielectric spectroscopy CDS: combination therapies: Drug Discovery & Development comparative systems biology: Genomic Manipulation & Disruption computational physiology: In Silico & Molecular Modeling computational sensing: Labels Signaling & detection Copy Number Polymorphisms CNPs: SNPs and Genetic Variations developability: Drug discovery & development diffusion tensor imaging: Molecular imaging drug metabolism: Pharmacogenomics evidence based toxicology: Drug safety & Pharmacovigilance exploratory IND: Drug approvals expressomics: -Omes & -omics follow-on drug: Drug discovery & development fragment based drug discovery Assays and screening genetic susceptibility: Molecular diagnostics -- genetic & genomic testing GIS Geographic Information Systems: Molecular Medicine and Diagnostics GSK: GlaxoSmithKline green chemistry: Chemistry & biology inflammasome: -Omes & -omics integrative and organ systems pharmacology: Pharmacogenomics in vitro diagnostic multivariate index assays IVDMIAs: Genetic & genomic testing label free detection: Labels Signaling & detection lead hopping: Assays mass spectrometry" IUPAC Mass Spectrometry Standard definitions of terms relating to mass spectrometry Provisional recommendations, 2006 http://www.iupac.org/reports/provisional/abstract06/murray_prs.pdf materials chemistry: Chemistry & biology medical resequencing: Sequencing mesoscopic biology: Expression genes & proteins microdosing Pharmacogenomics mitochondriomics: -Omes & -omics molecular biosensors: Labels Signaling & detection molecular crowding: Biomolecules molecular electronics: Nanoscience & miniaturization molecular events: Cancer genomics molecular pharmacology Pharmacogenomics nanolabels: Labels Signaling & detection nanomedicine: Nanoscience & miniaturization nanotechnology in the clinical laboratory setting: Molecular Medicine natural competence: DNA next generation sequencing: Sequencing -Omes
& -omics: Lots of new terms including
alleome, chromatinomics, chromosonics, cryobionomics, pharmacokinetics pharmacodynamics: Pharmacogenomics Phase zero, Phase O: Drug approvals pipeline problem: Drug discovery post-genomic chemistry: Chemistry & biology predictive ADME: Drug safety & pharmacovigilance predictive toxicology: Drug safety & pharmacovigilance process chemistry: Chemistry & biology Proteomic Standards Initiative: Proteomics resourceome: -Omes & -Omics ridiculome: -Omes & -Omics safety pharmacology: Drug Safety & Pharmacovigilance solubility: Chemistry & biology supramolecular electronics: Nanoscience & miniaturization systems pharmacology: Pharmacogenomics scaffold hopping: Chemistry target hopping: Drug targets therapeutic antibodies: Drug targets top-down mass spectrometry: Mass spectrometry glossary type 0, type I, type II biomarkers: Biomarkers women's health: Molecular Medicine and Diagnostics women's health statistical modeling: Molecular Medicine and Diagnostics Bibliography
|
Contact
| Privacy Statement |
Alphabetical
Glossary List | Tips & glossary
FAQs | Site Map
